FDA approves breakthrough injectable HIV medication Lenny Bernstein A breakthrough injectable drug combination for HIV, approved by the Food and Drug Administration on Thursday, will free some people from a daily pill regimen and may keep more of them on treatment that controls the infection, experts said. Cabenuva, the medication developed by a partnership of ViiV Healthcare and Janssen Pharmaceutical Companies, is given every four weeks by medical providers in the form of two injections. Four decades after the first case of HIV was identified, it is the latest and most convenient option for treating what has become a chronic, manageable — but still incurable — disease.